The launch comes as industry scrutiny around ingredient sourcing, contaminant control and supply chain resilience climbs, particularly in categories such as women’s health, prenatal nutrition and metabolic health where inositols, commonly referred to as vitamin B8, are widely used.
Most inositol ingredients currently on the market are produced from corn or wheat byproduct streams using chemical hydrolysis and purification processes, according to Renee Beall, director of marketing for food and nutrition at LBB Specialties.
“The traditional production route uses an impure byproduct stream from a grain wet mill combined with chemical conversion that can lead to worrisome potential contaminants including agriculture chemicals if the downstream purification process isn’t entirely effective,” she explained.
Manufacturers seek greater supply consistency
Interest in fermentation-derived alternatives is being driven in part by manufacturers looking for more consistent quality and clearer impurity profiles.
“Through precision fermentation, they are produced directly from clean, sugar-based inputs, avoiding the need for harsh chemical processing and enabling a more controlled, consistent, and transparent purity profile,” Beall explained.
The companies said the ingredients are bio-identical to conventional inositols, meaning formulators should not expect significant changes in functionality, solubility or bioavailability.
“The result is no change in performance but greater confidence in what’s behind it and where it comes from,” she said.
The ingredients are being positioned for use in applications where manufacturers place a high emphasis on ingredient quality and safety, including prenatal, infant nutrition and metabolic health products.
Women’s health demand continues to grow
The companies also linked interest in inositol ingredients to continued growth in women’s health formulations, particularly products targeting polycystic ovary syndrome (PCOS).
“An estimated 10–13% of women are affected by polycystic ovary syndrome (PCOS), and inositols have become a go-to ingredient as many consumers report noticeable benefits within weeks,” Beall said.
“As awareness grows, some brands are seeing category growth rates of up to 30%, which puts pressure on supply chains to deliver consistent, high-quality material at scale,” she noted.
Beyond women’s health, the companies’ interest in inositols is expanding into men’s health and metabolic support categories.
Shift away from conventional sourcing methods
The partnership also reflects broader efforts among supplement manufacturers to diversify ingredient sourcing and reduce dependence on conventional agricultural supply chains.
“The LBB Specialties - DMC partnership gives brands a smarter, strategic alternative to traditional inositol sourcing by replacing chemically synthesized or agriculture-extracted inputs with a precision-fermented solution,” Beall said.
“That shift reduces product variability and simplifies qualification for brands and manufacturers focused on quality and sustainability,” she added.
LBB Specialties announced earlier this month that it would distribute DMC’s KeyPura fermented myo-inositol and D-chiro-inositol ingredients across the United States and Canada for use in nutrition, food, personal care and life sciences applications.
